_version_ 1783637279144673280
author Rey, Esther
Ampuero, Javier
Molina‐Jiménez, Francisca
Marañón, Patricia
García‐García, Yaiza
Múñoz‐Hernández, Rocío
Romero‐Gómez, Manuel
García‐Monzón, Carmelo
Majano, Pedro
González‐Rodríguez, Águeda
author_facet Rey, Esther
Ampuero, Javier
Molina‐Jiménez, Francisca
Marañón, Patricia
García‐García, Yaiza
Múñoz‐Hernández, Rocío
Romero‐Gómez, Manuel
García‐Monzón, Carmelo
Majano, Pedro
González‐Rodríguez, Águeda
author_sort Rey, Esther
collection PubMed
description
format Online
Article
Text
id pubmed-7810262
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78102622021-01-22 Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation Rey, Esther Ampuero, Javier Molina‐Jiménez, Francisca Marañón, Patricia García‐García, Yaiza Múñoz‐Hernández, Rocío Romero‐Gómez, Manuel García‐Monzón, Carmelo Majano, Pedro González‐Rodríguez, Águeda Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-01-15 /pmc/articles/PMC7810262/ /pubmed/33463051 http://dx.doi.org/10.1002/ctm2.275 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Rey, Esther
Ampuero, Javier
Molina‐Jiménez, Francisca
Marañón, Patricia
García‐García, Yaiza
Múñoz‐Hernández, Rocío
Romero‐Gómez, Manuel
García‐Monzón, Carmelo
Majano, Pedro
González‐Rodríguez, Águeda
Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title_full Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title_fullStr Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title_full_unstemmed Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title_short Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
title_sort sofosbuvir improves hcv‐induced insulin resistance by blocking irs1 degradation
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810262/
https://www.ncbi.nlm.nih.gov/pubmed/33463051
http://dx.doi.org/10.1002/ctm2.275
work_keys_str_mv AT reyesther sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT ampuerojavier sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT molinajimenezfrancisca sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT maranonpatricia sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT garciagarciayaiza sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT munozhernandezrocio sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT romerogomezmanuel sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT garciamonzoncarmelo sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT majanopedro sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation
AT gonzalezrodriguezagueda sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation